Fluad

BIOLOGICAL11 trials

Sponsors

University of British Columbia, University of Surrey, Korea University Guro Hospital, University Hospital, Ghent, McMaster University

Conditions

Chronic Kidney DiseaseEnd Stage Renal FailureFlu VaccineHealthyHealthy AdultsHepatitis AInfluenzaInfluenza Vaccine

Phase 1

Effects of Aging on Primary and Secondary Vaccine Responses

CompletedNCT03312699

Stanford UniversityHealthy Adults, Hepatitis A, Influenza +1

Start: 2017-09-19End: 2023-12-31Updated: 2024-12-16

Phase 2

Systems Investigation of Vaccine Responses in Aging and Frailty

RecruitingNCT05291676

Yale UniversityInfluenza

Start: 2023-11-06End: 2027-04-30Target: 96Updated: 2025-06-12

Phase 4

Comparison of 4 Influenza Vaccines in Seniors

CompletedNCT01368796

University of British ColumbiaInfluenza Vaccine

Start: 2011-07-31End: 2012-05-31Updated: 2015-04-15

Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years

CompletedNCT02215863

Korea University Guro HospitalInfluenza, Streptococcus Pneumoniae

Start: 2014-09-30End: 2015-03-31Updated: 2015-04-01

Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses

CompletedNCT02523287

University Hospital, GhentSafety Markers of Adjuvanted Influenza Vaccine

Start: 2014-10-02End: 2016-08-01Updated: 2022-12-20

Immunogenicity of a Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Undergoing Hemodialysis

CompletedNCT02686398

Korea University Guro HospitalChronic Kidney Disease, End Stage Renal Failure, Influenza

Start: 2013-10-31End: 2014-11-30Updated: 2016-02-19

Adjuvanted Inactivated Vaccine Versus Inactivated Influenza Vaccine in Hutterite Children

CompletedNCT02871206

McMaster UniversityInfluenza

Start: 2016-11-30End: 2019-07-31Updated: 2024-11-21

Senescent Immunity in Elders and Vaccine Responses (SILVER)

CompletedNCT04077424

Vanderbilt University Medical CenterFlu Vaccine

Start: 2019-10-21End: 2020-02-01Updated: 2022-07-12

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

RecruitingNCT04101838

University of Alabama at BirminghamInfluenza

Start: 2021-04-01End: 2026-05-31Target: 50Updated: 2025-09-17

Unknown Phase

Training Study to Characterize Biomarkers to Flu Vaccines

CompletedNCT01771367

University of SurreyHealthy

Start: 2013-01-31End: 2013-11-30Updated: 2015-02-16

Gene Expression Profiles in Muscle After Immunisation

CompletedNCT02368327

University of SurreyHealthy

Start: 2015-02-28End: 2015-07-31Target: 45Updated: 2015-08-10

Related Papers

Adjuvant-attenuated symptom severity of influenza infections in vaccinated children.

2022-09-151 citations

Characterization of potential biomarkers of reactogenicity of licensed antiviral vaccines: randomized controlled clinical trials conducted by the BIOVACSAFE consortium.

2019-12-3029 citations

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in ⩾60-year-old adults.

2016-12-0321 citations

Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review.

2016-08-0430 citations

Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v).

2012-08-0763 citations